Jang-Han Lee, Chairman of Chong Kun Dang, "This Year Must Be Devoted to Solid Management"

On the 2nd, Chong Kun Dang announced that it held opening ceremonies at its headquarters in Chungjeong-ro, Seoul, its Hyojong Research Center in Yongin, Gyeonggi Province, and its Cheonan factory in Chungnam, officially starting its New Year's work.

Chairman Jang-Han Lee of Chong Kun Dang is delivering the New Year's address at the 2024 opening ceremony held on the 2nd.
[Photo by Chong Kun Dang]

In his New Year's address, Chairman Lee Jang-han of Chong Kun Dang stated, "This year should be a year focused on solid management to establish a foundation for sustainable growth." He continued, "It is important to secure Chong Kun Dang's unique pharmaceutical technologies that will lead future growth," emphasizing, "We will create new modalities that align with the new drug development paradigm, such as cell and gene therapies (CGT), antibody-drug conjugates (ADC), and antibody therapeutics, to continue enhancing the value of Chong Kun Dang's research and development achievements."

The chairman also said, "We will expand our product portfolio in various fields, including improved new drugs, over-the-counter (OTC) medicines, and digital drugs, to secure competitiveness," and added, "Until the day humanity is freed from all diseases, I ask all employees to do their best so that Chong Kun Dang can fulfill its mission as a pharmaceutical company."

This content was produced with the assistance of AI translation services.